Boisen Nadia, Melton-Celsa Angela R, Hansen Anne-Marie, Zangari Tonia, Smith Mark A, Russo Lisa M, Scheutz Flemming, O'Brien Alison D, Nataro James P
Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, VA, United States.
Front Microbiol. 2019 Aug 13;10:1824. doi: 10.3389/fmicb.2019.01824. eCollection 2019.
An O104:H4 Shiga toxin (Stx)-producing enteroaggregative (EAEC) strain caused a large outbreak of bloody diarrhea and the hemolytic uremic syndrome in 2011. We previously developed an ampicillin (Amp)-treated C57BL/6 mouse model to measure morbidity (weight loss) and mortality of mice orally infected with the prototype Stx-EAEC strain C227-11. Here, we hypothesized that mice fed C227-11 cured of the pAA plasmid or deleted for individual genes on that plasmid would display reduced virulence compared to animals given the wild-type (wt) strain. C227-11 cured of the pAA plasmid or deleted for the known pAA-encoded virulence genes , , , or were fed to Amp-treated C57BL/6 mice at doses of 10-10CFU. Infected animals were then either monitored for morbidity and lethality for 28 days or euthanized to determine intestinal pathology and colonization levels at selected times. The pAA-cured, , and mutants of strain C227-11 all showed reduced colonization at various intestinal sites. However, the mutant was the only mutant attenuated for virulence as it showed both reduced morbidity and mortality. The mutant showed increased expression of the aggregative adherence fimbriae (AAF) and caused greater systemic effects in infected mice when compared to the C227-11 wt strain. However, unexpectedly, both the and mutants displayed increased weight loss compared to wt. The mutant did not exhibit altered morbidity or mortality in the Amp-treated mouse model compared to wt. Our data suggest that the increased morbidity due to the mutant could possibly be via an effect on expression of an as yet unknown virulence-associated factor under AggR control.
一株产志贺毒素(Stx)的O104:H4肠聚集性(EAEC)菌株在2011年引发了大规模血性腹泻和溶血尿毒综合征疫情。我们之前构建了经氨苄青霉素(Amp)处理的C57BL/6小鼠模型,用于测定口服感染原型Stx-EAEC菌株C227-11的小鼠的发病率(体重减轻)和死亡率。在此,我们推测,与给予野生型(wt)菌株的动物相比,喂食不含pAA质粒或该质粒上个别基因缺失的C227-11的小鼠毒力会降低。将不含pAA质粒或已知的由pAA编码的毒力基因、、、缺失的C227-11以10⁷-10⁹CFU的剂量喂食给经Amp处理的C57BL/6小鼠。然后对感染动物监测28天的发病率和致死率,或在选定时间实施安乐死以确定肠道病理学和定植水平。C227-11的pAA缺失株、和突变株在各个肠道部位的定植均减少。然而,突变株是唯一毒力减弱的突变株,因为它的发病率和死亡率均降低。与C227-11 wt菌株相比,突变株的聚集性黏附菌毛(AAF)表达增加,且在感染小鼠中引起更大的全身效应。然而,出乎意料的是,与wt相比,和突变株的体重减轻均增加。与wt相比,突变株在经Amp处理的小鼠模型中未表现出发病率或死亡率的改变。我们的数据表明,突变株导致发病率增加可能是通过影响AggR控制下一个未知的毒力相关因子的表达。